IQ 577® Laser System – True yellow laser for retinal disorders

IQ577 Laser System from Iridex. NEW – MicroPulse® Laser Therapy for Fovea-Friendly™* laser grids and tissue-sparing* combo therapies. High transmission through dense ocular media. Dual Port for efficient setup of alternate delivery devices. Repeatable macular and foveal laser sessions. Maximize workflow efficiency.

True Yellow, 577nm wavelength for precise performance

High transmission through dense ocular media
Consistent laser lesions for fast procedure time
Low power required for increased patient comfort

Intelligent and intuitive design

Dual Port for efficient setup of alternate delivery devices
Intuitive graphic touch screen interface for ease of use
Programmable memory presets for multiple users

Optional Module for MicroPulse Laser Therapy

Repeatable macular and foveal laser sessions
Success with refractory and sub-clincal edema

IQ 577^® Laser System
Wavelength	577 nm Yellow
Weight	19.2 lb (9.0 kg)
Dimensions	8.5″ H x 12″ W x 14″ D (21 cm x 30 cm x 35 cm)
Connector Type	RFID \| Resistor
Electrical	100-240 VAC, 50/60 Hz
Cooling	Whisper fan
Exposure Duration	CW-Pulse: 10-3000 ms
Exposure Interval	CW-Pulse: 10-3000 ms
MicroPulse Duration	MicroPulse: 0.05-1.00 ms
MicroPulse Interval	MicroPulse: 1.00-10.00 ms
Aiming Laser	Diode laser, 635 nm nominal
Delivery Device Power Output	Portable SLA: 0-2000 mW LIO: 0-2000 mW EndoProbe: 0-2000 mW

Optional Accessories

Full-Featured Remote Control

Compact design for easy placement or use in sterile field
View displays and adjust parameters from two vantage points for increased convenience and efficiency

Wireless Footswitch

No cord, no clutter, no limitations
Allows precise physician control over power settings
Available with power-adjust to control laser actuation and power settings

Munir Escaf, MD.
Retina Specialist Clinica Carriazo. Barranquilla Atlantico, Columbia

Jonathan Feistman, MD.
Retina Specialist NYC Retina. New York City, NY

Brian Horsman, MD.
Director, Retina Group Barnet Dulaney Perkins Eye Center. Phoenix, AZ USA

Brandon Johnson, MD.
NYC Retina. New York, NY USA

Ahad Mahootchi, MD.
Medical Director The Eye Clinic of Florida. Zephyrhills, FL

Walid Mangal, DO
Florida Vision Institute. Stuart, FL USA

“By incorporating MicroPulse, my injection burden decreases by one-third at a minimum, which is a conservative estimate. The versatility of MicroPulse to treat retinal disorders and glaucoma allows me to provide my patients with a treatment that’s clinically effective, cost effective, and time effective.””MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications.”

Jason Friedrichs, MD, MS Friedrichs Eye Sycamore, IL USA

“The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye.”

Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT USA

IRIDEX at the American Academy of Ophthalmology 2018

Tratamiento Para la Retina con Láser MicroPulse de IRIDEX – Dr. Munir Escaf

The Role of Laser Therapy in the Treatment of Retinal Diseases

“MLT is versatile in variety of ways: for patients just starting therapy, replacing an eye drop, as an adjunct to an eye drop or to keep them away from incisional surgery.”

Nathan Radcliffe, MD. New York Eye Surgery Center Bronx, NY USA

“I achieved such good results with MLT that I decided to try MicroPulse for treating retinal diseases. I now use it daily to treat many retinal disorders, and MicroPulse allows me to treat patients who I could not have otherwise.”

Brandon Philips, MD. Carolina Vision Center Fayetteville, NC USA